Edge Wealth Management LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 229 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Edge Wealth Management LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,146,000
+8.0%
121,295
+2.4%
0.26%
+31.3%
Q2 2020$1,061,000
+29.4%
118,401
-10.3%
0.20%
+12.9%
Q1 2020$820,000
+39.0%
132,021
+86.5%
0.18%
+50.8%
Q4 2019$590,000
-5.3%
70,777
+2.8%
0.12%
-17.5%
Q3 2019$623,000
-15.4%
68,8690.0%0.14%
-12.3%
Q2 2019$736,000
+9.0%
68,869
-2.7%
0.16%
-1.8%
Q1 2019$675,000
+17.8%
70,800
+42.0%
0.17%
+2.5%
Q4 2018$573,000
-34.6%
49,870
-3.5%
0.16%
-22.9%
Q3 2018$876,000
+54.2%
51,680
+29.2%
0.21%
+44.8%
Q2 2018$568,00040,0130.14%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders